Evaluation of the safety profile of selective COX-2 inhibitors in patients with Non-Steroidal Anti-Inflammatory Drugs (NSAID) reactions in Brazil

被引：0
|
作者：
Lacerda, A. E. [1 ]
Piza, C. F. S. T. [2 ]
Marcelino, F. C. [3 ]
Camelo-Nunes, I. C. [1 ]
Ensina, L. F. [1 ]
机构：
[1] Univ Fed Sao Paulo, Sao Paulo, Brazil
[2] Sao Leopoldo Mand Med Sch, Campinas, Brazil
[3] HRAN Hosp Reg Asa Norte, Brasilia, DF, Brazil
来源：
ALLERGY | 2020年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
0555
引用
收藏
页码：215 / 215
页数：1
相关论文
共 50 条
  • [41] Maligned non-steroidal anti-inflammatory drugs:Misunderstanding of their safety profile in patients with renal insufficiency
    Bruce M Rothschild
    World Journal of Rheumatology, 2018, (01) : 1 - 4
  • [42] Cyclooxygenase (COX)-2 Selective and Non-Selective Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Risk of Hyperkalemia
    Lafrance, Jean-Philippe
    Miller, Donald R.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 : S110 - S111
  • [43] Re: Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations: implications for COX-2 cardiovascular profile
    van Staa, Tjeerd P.
    Parkinson, J.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (11) : 1253 - 1254
  • [44] Rational basis for the use of non-steroidal antiinflammatory drugs (and selective COX-2 inhibitors)
    Brune, K
    Hinz, B
    Zeilhofer, HU
    AKTUELLE RHEUMATOLOGIE, 1999, 24 (04) : 102 - 108
  • [45] Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations. Implications for COX-2 cardiovascular profile
    Arellano, Felix M.
    Yood, Marianne Ulcickas
    Wentworth, Charles E.
    Oliveria, Susan A.
    Rivero, Elena
    Verma, Anila
    Rothman, Kenneth J.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 (12) : 861 - 872
  • [46] Pharmacology of meloxicam, a new non-steroidal anti-inflammatory drug with an improved safety profile through preferential inhibition of COX-2
    Engelhardt, G
    BRITISH JOURNAL OF RHEUMATOLOGY, 1996, 35 : 4 - 12
  • [47] The administration of non-steroidal anti-inflammatory drugs and selective cyclooxygenase-2 inhibitors in dentistry
    Vardar, S
    CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (14) : 1735 - 1736
  • [48] Use of Non-Steroidal Anti-Inflammatory Drugs and Heart Failure Risk in the Safety of Non-Steroidal Anti-Inflammatory Drugs (SOS) Project
    Arfe, Andrea
    Kollhorst, Bianca
    Schink, Tania
    Garbe, Edeltraut
    Herings, Ron
    Straatman, Huub
    Schade, Rene
    Villa, Marco
    Lucchi, Silvia
    Nicotra, Federica
    Valkhoff, Vera
    Romio, Silvana
    Thiessard, Frantz
    Schuemie, Martijn
    Varas Lorenzo, Cristina
    Pariente, Antoine
    Sturkenboom, Miriam
    Zambon, Antonella
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 408 - 409
  • [49] Renal effects of non-steroidal anti-inflammatory drugs and selective cyclooxygenase-2 inhibitors
    Cheng, HF
    Harris, RC
    CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (14) : 1795 - 1804
  • [50] NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
    BISCARINI, L
    DELFAVERO, A
    MEDICINA-RIVISTA DELLA ENCICLOPEDIA MEDICA ITALIANA, 1989, 9 (03): : 249 - 264
12345